CN Stock MarketDetailed Quotes

002390 Guizhou Xinbang Pharmaceutical

Watchlist
  • 3.95
  • -0.03-0.75%
Not Open May 15 15:00 CST
7.68BMarket Cap26.16P/E (TTM)

Guizhou Xinbang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-1.41%1.58B
1.75%6.46B
2.92%4.82B
3.59%3.26B
1.70%1.61B
-1.88%6.35B
-0.78%4.69B
1.46%3.14B
8.10%1.58B
10.71%6.47B
Operating revenue
-1.41%1.58B
1.75%6.46B
2.92%4.82B
3.59%3.26B
1.70%1.61B
-1.88%6.35B
-0.78%4.69B
1.46%3.14B
8.10%1.58B
10.71%6.47B
Other operating revenue
----
29.04%24.98M
----
-0.01%17.06M
----
-37.07%19.36M
----
-2.59%17.07M
----
17.50%30.76M
Total operating cost
-2.33%1.5B
0.24%6.03B
1.39%4.47B
2.12%3.03B
3.00%1.54B
0.20%6.02B
-0.30%4.41B
1.71%2.97B
8.57%1.49B
9.43%6B
Operating cost
-0.53%1.31B
1.93%5.23B
3.25%3.86B
4.37%2.62B
3.31%1.31B
0.27%5.13B
0.20%3.74B
2.10%2.51B
10.39%1.27B
11.45%5.12B
Operating tax surcharges
0.79%6.93M
-2.69%27.43M
0.37%20.84M
3.73%13.32M
-0.48%6.88M
-1.80%28.19M
-0.49%20.76M
4.70%12.84M
17.04%6.91M
20.04%28.7M
Operating expense
-14.94%72.87M
-12.70%343.41M
-13.80%254.85M
-10.01%173.66M
-6.45%85.66M
9.21%393.37M
3.10%295.66M
5.05%192.98M
1.06%91.57M
-9.75%360.19M
Administration expense
-8.57%106.72M
-6.26%394.42M
-1.51%308.01M
-8.16%206.64M
9.89%116.73M
3.53%420.77M
4.16%312.75M
13.59%224.99M
10.56%106.22M
7.97%406.43M
Financial expense
-56.33%4.88M
-28.80%27.75M
-40.07%24.41M
-40.65%16.08M
-19.04%11.18M
-55.28%38.98M
-50.71%40.74M
-58.33%27.09M
-50.03%13.81M
5.34%87.17M
-Interest expense (Financial expense)
-51.86%6.66M
-23.34%39.7M
-31.80%32.37M
-29.77%21.57M
-10.06%13.84M
-48.31%51.79M
-49.74%47.45M
-58.57%30.7M
-52.56%15.38M
0.58%100.19M
-Interest Income (Financial expense)
29.41%-2.02M
5.98%-12.73M
-18.01%-8.59M
-39.92%-5.96M
-47.97%-2.86M
3.30%-13.54M
41.48%-7.28M
55.50%-4.26M
61.89%-1.93M
8.88%-14M
Research and development
25.24%865.89K
287.11%4.67M
354.16%2.05M
521.04%1.67M
398.74%691.39K
-37.70%1.21M
-39.56%450.76K
-70.63%268.29K
-68.49%138.63K
-81.66%1.94M
Credit Impairment Loss
-1,431.52%-3.34M
15.18%-53.13M
-74.44%-16.73M
-102.25%-16.74M
-10.27%251.09K
-107.61%-62.63M
13.00%-9.59M
0.62%-8.28M
115.84%279.85K
50.25%-30.17M
Asset Impairment Loss
----
---7.52M
----
----
----
----
----
----
----
----
Other net revenue
-280.33%-2.38M
-152.91%-45.85M
-138.54%-12.62M
-239.95%-14.77M
-2.37%1.32M
-9.50%-18.13M
2,705.15%32.75M
-345.88%-4.34M
-81.21%1.35M
76.98%-16.56M
Invest income
----
-74.89%9.4M
-102.11%-788.94K
-17,250.95%-2.03M
--4.57K
854.70%37.43M
1,043.54%37.43M
-99.62%11.86K
----
123.10%3.92M
-Including: Investment income associates
----
----
----
----
----
----
----
----
----
--47.4K
Asset deal income
69.00%-11.75K
493.81%17.8K
25.54%-55.86K
49.25%-43.05K
71.28%-37.88K
98.93%-4.52K
5.54%-75.03K
-293.01%-84.82K
-385.92%-131.91K
75.05%-423.08K
Other revenue
-11.13%977.96K
-23.98%5.38M
-0.81%4.95M
1.15%4.05M
-8.47%1.1M
-29.99%7.08M
-44.51%5M
-42.51%4.01M
-78.16%1.2M
28.39%10.11M
Operating profit
13.32%80.6M
21.72%385.03M
9.77%339.85M
23.40%208.76M
-20.11%71.12M
-29.94%316.32M
2.71%309.61M
-5.98%169.18M
-5.58%89.03M
57.10%451.51M
Add:Non operating Income
-76.92%281.04K
125.26%25.01M
-47.38%2.36M
-67.45%1.46M
447.32%1.22M
20.97%11.1M
-34.12%4.49M
-27.06%4.48M
-58.75%222.52K
224.68%9.18M
Less:Non operating expense
758.24%1.29M
-0.07%14.02M
50.73%6.51M
394.16%1.4M
-48.22%150.05K
-64.53%14.03M
-86.32%4.32M
-95.03%283.06K
-92.52%289.78K
73.72%39.56M
Total profit
10.25%79.59M
26.37%396.02M
8.37%335.7M
20.44%208.82M
-18.85%72.19M
-25.58%313.39M
11.97%309.78M
-3.89%173.38M
-2.20%88.96M
57.46%421.12M
Less:Income tax cost
-17.24%7.9M
-6.40%42.25M
-2.43%32.26M
-0.82%17.22M
1.23%9.54M
-4.31%45.14M
-3.01%33.06M
-21.13%17.37M
-27.11%9.43M
0.62%47.17M
Net profit
14.44%71.69M
31.88%353.77M
9.66%303.45M
22.81%191.6M
-21.23%62.65M
-28.27%268.26M
14.07%276.72M
-1.50%156.01M
1.93%79.54M
69.54%373.96M
Net profit from continuing operation
14.44%71.69M
31.95%353.77M
9.66%303.45M
22.81%191.6M
-21.23%62.65M
-28.30%268.12M
14.07%276.72M
-1.50%156.01M
1.93%79.54M
69.54%373.96M
Net income from discontinuing operating
----
----
----
----
----
--139.48K
----
----
----
----
Less:Minority Profit
32.62%12.87M
51.64%66.54M
59.34%56.87M
45.13%35.58M
60.17%9.7M
-56.59%43.88M
9.81%35.69M
326.27%24.51M
3.63%6.06M
114.83%101.09M
Net profit of parent company owners
11.11%58.82M
28.02%287.23M
2.30%246.57M
18.65%156.02M
-27.94%52.94M
-17.77%224.37M
14.73%241.03M
-13.84%131.5M
1.80%73.48M
57.25%272.87M
Earning per share
Basic earning per share
0.00%0.03
25.00%0.15
2.42%0.127
18.79%0.0803
-25.00%0.03
-20.00%0.12
0.57%0.124
-29.88%0.0676
-20.00%0.04
36.36%0.15
Diluted earning per share
0.00%0.03
25.00%0.15
2.42%0.127
18.79%0.0803
-25.00%0.03
-20.00%0.12
0.57%0.124
-29.88%0.0676
-20.00%0.04
36.36%0.15
Other composite income
Total composite income
14.44%71.69M
31.88%353.77M
9.66%303.45M
22.81%191.6M
-21.23%62.65M
-28.27%268.26M
14.07%276.72M
-1.50%156.01M
1.93%79.54M
68.98%373.96M
Total composite income of parent company owners
11.11%58.82M
28.02%287.23M
2.30%246.57M
18.65%156.02M
-27.94%52.94M
-17.77%224.37M
14.73%241.03M
-13.84%131.5M
1.80%73.48M
56.60%272.87M
Total composite income of minority owners
32.62%12.87M
51.64%66.54M
59.34%56.87M
45.13%35.58M
60.17%9.7M
-56.59%43.88M
9.81%35.69M
326.27%24.51M
3.63%6.06M
114.83%101.09M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -1.41%1.58B1.75%6.46B2.92%4.82B3.59%3.26B1.70%1.61B-1.88%6.35B-0.78%4.69B1.46%3.14B8.10%1.58B10.71%6.47B
Operating revenue -1.41%1.58B1.75%6.46B2.92%4.82B3.59%3.26B1.70%1.61B-1.88%6.35B-0.78%4.69B1.46%3.14B8.10%1.58B10.71%6.47B
Other operating revenue ----29.04%24.98M-----0.01%17.06M-----37.07%19.36M-----2.59%17.07M----17.50%30.76M
Total operating cost -2.33%1.5B0.24%6.03B1.39%4.47B2.12%3.03B3.00%1.54B0.20%6.02B-0.30%4.41B1.71%2.97B8.57%1.49B9.43%6B
Operating cost -0.53%1.31B1.93%5.23B3.25%3.86B4.37%2.62B3.31%1.31B0.27%5.13B0.20%3.74B2.10%2.51B10.39%1.27B11.45%5.12B
Operating tax surcharges 0.79%6.93M-2.69%27.43M0.37%20.84M3.73%13.32M-0.48%6.88M-1.80%28.19M-0.49%20.76M4.70%12.84M17.04%6.91M20.04%28.7M
Operating expense -14.94%72.87M-12.70%343.41M-13.80%254.85M-10.01%173.66M-6.45%85.66M9.21%393.37M3.10%295.66M5.05%192.98M1.06%91.57M-9.75%360.19M
Administration expense -8.57%106.72M-6.26%394.42M-1.51%308.01M-8.16%206.64M9.89%116.73M3.53%420.77M4.16%312.75M13.59%224.99M10.56%106.22M7.97%406.43M
Financial expense -56.33%4.88M-28.80%27.75M-40.07%24.41M-40.65%16.08M-19.04%11.18M-55.28%38.98M-50.71%40.74M-58.33%27.09M-50.03%13.81M5.34%87.17M
-Interest expense (Financial expense) -51.86%6.66M-23.34%39.7M-31.80%32.37M-29.77%21.57M-10.06%13.84M-48.31%51.79M-49.74%47.45M-58.57%30.7M-52.56%15.38M0.58%100.19M
-Interest Income (Financial expense) 29.41%-2.02M5.98%-12.73M-18.01%-8.59M-39.92%-5.96M-47.97%-2.86M3.30%-13.54M41.48%-7.28M55.50%-4.26M61.89%-1.93M8.88%-14M
Research and development 25.24%865.89K287.11%4.67M354.16%2.05M521.04%1.67M398.74%691.39K-37.70%1.21M-39.56%450.76K-70.63%268.29K-68.49%138.63K-81.66%1.94M
Credit Impairment Loss -1,431.52%-3.34M15.18%-53.13M-74.44%-16.73M-102.25%-16.74M-10.27%251.09K-107.61%-62.63M13.00%-9.59M0.62%-8.28M115.84%279.85K50.25%-30.17M
Asset Impairment Loss -------7.52M--------------------------------
Other net revenue -280.33%-2.38M-152.91%-45.85M-138.54%-12.62M-239.95%-14.77M-2.37%1.32M-9.50%-18.13M2,705.15%32.75M-345.88%-4.34M-81.21%1.35M76.98%-16.56M
Invest income -----74.89%9.4M-102.11%-788.94K-17,250.95%-2.03M--4.57K854.70%37.43M1,043.54%37.43M-99.62%11.86K----123.10%3.92M
-Including: Investment income associates --------------------------------------47.4K
Asset deal income 69.00%-11.75K493.81%17.8K25.54%-55.86K49.25%-43.05K71.28%-37.88K98.93%-4.52K5.54%-75.03K-293.01%-84.82K-385.92%-131.91K75.05%-423.08K
Other revenue -11.13%977.96K-23.98%5.38M-0.81%4.95M1.15%4.05M-8.47%1.1M-29.99%7.08M-44.51%5M-42.51%4.01M-78.16%1.2M28.39%10.11M
Operating profit 13.32%80.6M21.72%385.03M9.77%339.85M23.40%208.76M-20.11%71.12M-29.94%316.32M2.71%309.61M-5.98%169.18M-5.58%89.03M57.10%451.51M
Add:Non operating Income -76.92%281.04K125.26%25.01M-47.38%2.36M-67.45%1.46M447.32%1.22M20.97%11.1M-34.12%4.49M-27.06%4.48M-58.75%222.52K224.68%9.18M
Less:Non operating expense 758.24%1.29M-0.07%14.02M50.73%6.51M394.16%1.4M-48.22%150.05K-64.53%14.03M-86.32%4.32M-95.03%283.06K-92.52%289.78K73.72%39.56M
Total profit 10.25%79.59M26.37%396.02M8.37%335.7M20.44%208.82M-18.85%72.19M-25.58%313.39M11.97%309.78M-3.89%173.38M-2.20%88.96M57.46%421.12M
Less:Income tax cost -17.24%7.9M-6.40%42.25M-2.43%32.26M-0.82%17.22M1.23%9.54M-4.31%45.14M-3.01%33.06M-21.13%17.37M-27.11%9.43M0.62%47.17M
Net profit 14.44%71.69M31.88%353.77M9.66%303.45M22.81%191.6M-21.23%62.65M-28.27%268.26M14.07%276.72M-1.50%156.01M1.93%79.54M69.54%373.96M
Net profit from continuing operation 14.44%71.69M31.95%353.77M9.66%303.45M22.81%191.6M-21.23%62.65M-28.30%268.12M14.07%276.72M-1.50%156.01M1.93%79.54M69.54%373.96M
Net income from discontinuing operating ----------------------139.48K----------------
Less:Minority Profit 32.62%12.87M51.64%66.54M59.34%56.87M45.13%35.58M60.17%9.7M-56.59%43.88M9.81%35.69M326.27%24.51M3.63%6.06M114.83%101.09M
Net profit of parent company owners 11.11%58.82M28.02%287.23M2.30%246.57M18.65%156.02M-27.94%52.94M-17.77%224.37M14.73%241.03M-13.84%131.5M1.80%73.48M57.25%272.87M
Earning per share
Basic earning per share 0.00%0.0325.00%0.152.42%0.12718.79%0.0803-25.00%0.03-20.00%0.120.57%0.124-29.88%0.0676-20.00%0.0436.36%0.15
Diluted earning per share 0.00%0.0325.00%0.152.42%0.12718.79%0.0803-25.00%0.03-20.00%0.120.57%0.124-29.88%0.0676-20.00%0.0436.36%0.15
Other composite income
Total composite income 14.44%71.69M31.88%353.77M9.66%303.45M22.81%191.6M-21.23%62.65M-28.27%268.26M14.07%276.72M-1.50%156.01M1.93%79.54M68.98%373.96M
Total composite income of parent company owners 11.11%58.82M28.02%287.23M2.30%246.57M18.65%156.02M-27.94%52.94M-17.77%224.37M14.73%241.03M-13.84%131.5M1.80%73.48M56.60%272.87M
Total composite income of minority owners 32.62%12.87M51.64%66.54M59.34%56.87M45.13%35.58M60.17%9.7M-56.59%43.88M9.81%35.69M326.27%24.51M3.63%6.06M114.83%101.09M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg